Document is current
Any future updates will be listed below
-
Authors
Camilleri, Michael
- License Information
-
More Information
Article History
Accepted: 5 May 2021
First Online: 26 May 2021
Declarations
:
: Michael Camilleri has received research grants from Novartis for study of tropifexor and from Allergan for study of eluxadoline in bile acid diarrhea. Though Dr. Camilleri is a full-time employee of Mayo Clinic which commercializes serum C4 and fecal bile acid measurements for bile acid diarrhea, Dr. Camilleri has no personal financial conflict of interest.
Free to read: This content has been made available to all.
